Logo image of ELYM

ELIEM THERAPEUTICS INC (ELYM) Stock Analyst Ratings

NASDAQ:ELYM - Nasdaq - US28658R1068 - Common Stock

5.11  -0.05 (-0.97%)

After market: 5.1 -0.01 (-0.2%)

Buy % Consensus

43

ChartMill assigns a Buy % Consensus number of 43% to ELYM. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 4.59. This target is -10.18% below the current price.
ELYM was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about ELYM.
In the previous month the buy percentage consensus was at a similar level.
ELYM was analyzed by 6 analysts. More opinions would make the average more meaningful.

Related screens

ELYM Historical Analyst RatingsELYM Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -25 -23 -21 -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 5.114.044.594.595.25 - -20.94% -10.18% -10.18% 2.74%

Related screens

ELYM Current Analyst RatingELYM Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades
Date Firm Action Rating
2023-03-08 HC Wainwright & Co. Reiterate Neutral
2023-02-10 HC Wainwright & Co. Downgrade Buy -> Neutral
2022-10-28 HC Wainwright & Co. Initiate Buy
2022-08-16 SVB Leerink Maintains Outperform
2022-07-11 SVB Leerink Maintains Outperform
2022-04-26 Guggenheim Downgrade Buy -> Neutral
2022-04-26 SVB Leerink Maintains Outperform
2021-09-07 Guggenheim Initiate Buy
2021-09-07 SVB Leerink Initiate Outperform
2021-09-07 Stifel Initiate Buy